Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Cases and Controversies in HIV in 2020: A Global Perspective
  • CME

Credits Available
Physicians: maximum of 1.5 AMA PRA Category 1 Credits
Released: December 22, 2020 Expiration: December 21, 2021
Start Activity
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences, Inc.
José R. Arribas, MD
Andrew Carr, MBBS, MD, FRACP, FRCPA
person default
Lynora Saxinger, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Appropriately evaluate potential adverse events and drug–drug interactions associated with ART initiation and switching ART
  • Effectively manage diverse patient populations who face challenges due to drug–drug interactions, adverse events, and other complications associated with HIV, ART, and comorbidities
  • Appropriately appraise ART switch strategies for individual patients

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty

José R. Arribas, MD

Research Director (HIV and Infectious Diseases)
Hospital La Paz. IdiPAZ.
Madrid, Spain

José R. Arribas, MD, has disclosed that he has received funds for research support from Gilead Sciences, Merck, and ViiV Healthcare and consulting fees from Aelix, Gilead Sciences, Janssen, Merck, Teva, and ViiV Healthcare.
Andrew Carr, MBBS, MD, FRACP, FRCPA

Professor of Medicine
University of New South Wales
Director, HIV and Immunology Unit
St Vincent's Hospital
Sydney, Australia

Andrew Carr, MBBS, MD, FRACP, FRCPA, has disclosed that he has received consulting fees and funds for research support from Gilead Sciences, MSD, and ViiV Healthcare and fees for non-CME/CE services from Gilead Sciences and ViiV Healthcare.
Lynora Saxinger, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Lynora Saxinger, MD, FRCPC, CTropMed, has no relevant conflicts of interest to report.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Scientific Director

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians and other healthcare providers who care for patients with HIV.

Goal

The goal of this activity is to improve clinicians’ competence in addressing the most important and most current challenges in HIV disease management by providing a tightly focused update on recent advances and key issues encountered in the clinic.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 22, 2020, through December 21, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Didactic Overview: ARV-Associated Weight Gain
  • CME

Dr. Andrew Carr discusses key data and outstanding questions related to ARV-associated weight gain.
José R. Arribas, MD
Andrew Carr, MBBS, MD, FRACP, FRCPA
person default
Lynora Saxinger, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits
Released: December 22, 2020 Expiration: December 21, 2021

This program is divided into several short segments which you can step through using the Video Chapters menu.
PreviousNext

Related Content

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Expert commentary on managing a TB outbreak in a socially and medically complex population of patients living with HIV

Nicky Mehtani, MD, MPH Released: February 22, 2021

CCO video featuring a discussion between Dr. Princy Kumar and Dr. Brian Wood on assessing virologic failure in a heavily treatment-experienced patient

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

Únase al Dr. Luis Gerardo García Demuner, experto de CCO, en el trayecto de un paciente con VIH en búsqueda de atención médica durante la epidemia de la COVID-19 en México.

person default Luis G. García Demuner, MD Released: February 12, 2021

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue